Race Oncology Ltd (RAC) - Total Liabilities

Latest as of June 2026: AU$1.64 Million AUD ≈ $1.16 Million USD

Based on the latest financial reports, Race Oncology Ltd (RAC) has total liabilities worth AU$1.64 Million AUD (≈ $1.16 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore RAC strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Race Oncology Ltd - Total Liabilities Trend (2011–2026)

This chart illustrates how Race Oncology Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Race Oncology Ltd balance sheet assets.

Race Oncology Ltd Competitors by Total Liabilities

The table below lists competitors of Race Oncology Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Linzhou Heavy Machinery Group Co Ltd SHE:002535	China	CN¥2.97 Billion
Kendrion NV AS:KENDR	Netherlands	€117.10 Million
Dirui Industrial Co Ltd SHE:300396	China	CN¥1.02 Billion
Lionheart Holdings Unit NASDAQ:CUBWU	USA	$10.07 Million
WATERDROP INC.ADS/10 CL.A F:717	Germany	€2.56 Billion
YG-1 Co. Ltd KQ:019210	Korea	₩761.54 Billion
Lavipharm S.A AT:LAVI	Greece	€72.52 Million
SungEel HiTech Co. Ltd. KQ:365340	Korea	₩542.36 Billion

Liability Composition Analysis (2011–2026)

This chart breaks down Race Oncology Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Race Oncology Ltd to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	21.43	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Race Oncology Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Race Oncology Ltd (2011–2026)

The table below shows the annual total liabilities of Race Oncology Ltd from 2011 to 2026.

Year	Total Liabilities	Change
2026-06-30	AU$1.64 Million ≈ $1.16 Million	+11.14%
2025-06-30	AU$1.48 Million ≈ $1.05 Million	-22.85%
2024-06-30	AU$1.92 Million ≈ $1.36 Million	+66.39%
2023-06-30	AU$1.15 Million ≈ $814.97K	-18.74%
2022-06-30	AU$1.42 Million ≈ $1.00 Million	+170.95%
2021-06-30	AU$523.11K ≈ $370.13K	+114.70%
2020-06-30	AU$243.65K ≈ $172.40K	+26.82%
2019-06-30	AU$192.12K ≈ $135.94K	-37.97%
2018-06-30	AU$309.71K ≈ $219.14K	-14.82%
2017-06-30	AU$363.57K ≈ $257.25K	-7.16%
2016-06-30	AU$391.62K ≈ $277.10K	+229.70%
2015-06-30	AU$118.78K ≈ $84.04K	-10.05%
2014-06-30	AU$132.05K ≈ $93.43K	-99.93%
2013-12-31	AU$191.01 Million ≈ $135.15 Million	+1611781.86%
2013-06-30	AU$11.85K ≈ $8.38K	-100.00%
2012-12-31	AU$264.98 Million ≈ $187.49 Million	-20.07%
2012-06-30	AU$331.51 Million ≈ $234.56 Million	+21.34%
2011-06-30	AU$273.20 Million ≈ $193.31 Million	--

About Race Oncology Ltd

AU:RAC Australia Biotechnology

Market Cap

$287.17 Million

AU$405.86 Million AUD

Market Cap Rank

#15191 Global

#405 in Australia

Share Price

AU$2.07

Change (1 day)

-0.96%

52-Week Range

AU$1.93 - AU$4.70

All Time High

AU$4.70